High Purity Abiraterone Acetate CAS 154229-18-2: Essential Pharmaceutical Raw Material for Prostate Cancer Treatment
Discover the critical role of high-purity Abiraterone Acetate (CAS 154229-18-2) as a vital pharmaceutical raw material, specifically formulated for the treatment of castration-resistant prostate cancer. Learn about its function as a potent CYP17 inhibitor and its advantages as a reliable supplier in China.
Get a Quote & SampleProduct Core Value
Abiraterone Acetate
Abiraterone Acetate (CAS 154229-18-2) is a high-purity raw material, essential for advanced prostate cancer treatment. As a leading supplier in China, we provide this vital pharmaceutical intermediate known for its efficacy as a CYP17 inhibitor. Its formulation as a prodrug is key to its therapeutic action in castration-resistant prostate cancer (CRPC).
- Explore the benefits of buying Abiraterone Acetate, a key component in effective prostate cancer treatment, ensuring high standards for pharmaceutical formulations.
- Understand the critical function of this pharmaceutical intermediate, CAS 154229-18-2, in inhibiting CYP17, a crucial step in treating advanced prostate cancer.
- Learn about the high purity (99%) of our Abiraterone Acetate raw material, making it an ideal choice for stringent pharmaceutical manufacturing processes.
- Discover why sourcing this essential component from a reliable manufacturer in China provides a competitive edge in pharmaceutical supply chains.
Advantages Offered
Superior Purity for Pharmaceutical Use
Our Abiraterone Acetate raw material boasts a purity of 99%, ensuring it meets the rigorous demands for pharmaceutical applications, contributing to the efficacy of prostate cancer treatment drugs.
Targeted Therapeutic Action
As a potent CYP17 inhibitor, Abiraterone Acetate is instrumental in advanced cancer treatment, specifically for CRPC, offering a focused therapeutic approach.
Reliable Sourcing from China
Partnering with a trusted manufacturer in China for your Abiraterone Acetate supply chain ensures consistent quality and availability, supporting your procurement needs for this critical pharmaceutical intermediate.
Key Applications
Prostate Cancer Therapeutics
Abiraterone Acetate is a cornerstone in the treatment of castration-resistant prostate cancer, offering a vital therapeutic option for patients and underscoring its importance in oncology drug development.
Pharmaceutical Manufacturing
As a key pharmaceutical intermediate, Abiraterone Acetate is indispensable for drug manufacturers producing advanced treatments, emphasizing the need for high-quality raw materials.
Chemical Synthesis
The synthesis of complex pharmaceutical compounds relies on precisely manufactured intermediates like Abiraterone Acetate, highlighting its role in advanced chemical synthesis for medical purposes.
Oncology Drug Development
The development of new and improved cancer therapies frequently involves specialized compounds like Abiraterone Acetate, supporting innovation in the medical field.